ask="2.75"
ask_size="1000"
average_daily_volume="1042670"
bid="2.25"
bid_size="2200"
book_value="-0.03"
change="+0.12"
change_from_200_day_moving_average="0.93"
change_from_50_day_moving_average="0.59"
change_from_52_week_high="-1.41"
change_From_52_week_low="1.57"
change_in_percent="+4.69%"
close="2.68"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-13.34M"
eps_estimate_current_year="-1.23"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="0.95"
ex_dividend_date="N/A"
float_shares="4867000"
high="2.75"
high_52_weeks="4.09"
last_trade_date="3/10/2017"
last_trade_price="2.68"
last_trade_size="1768"
last_trade_time="4:00pm"
low="2.55"
low_52_weeks="1.11"
market_capitalization="27.43M"
moving_average_200_day="1.75"
moving_average_50_day="2.09"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="8.00"
open="2.55"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+53.22%"
percent_change_from_50_day_moving_average="+28.24%"
percent_change_from_52_week_high="-34.47%"
percent_change_from_52_week_low="+141.44%"
previous_close="2.56"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="2.82"
price_per_book="N/A"
price_per_sales="39.15"
revenue="669259.00"
shares_outstanding="10234000"
short_ratio="1.02"
stock_exchange="NCM"
symbol="EYEG"
volume="347254"
weeks_range_52="1.11 - 4.09"
